vs
Side-by-side financial comparison of Liberty Latin America Ltd. (LILA) and Zoetis (ZTS). Click either name above to swap in a different company.
Zoetis is the larger business by last-quarter revenue ($2.3B vs $1.2B, roughly 2.0× Liberty Latin America Ltd.). Zoetis runs the higher net margin — 26.6% vs -4.7%, a 31.3% gap on every dollar of revenue. On growth, Zoetis posted the faster year-over-year revenue change (2.9% vs 1.7%). Over the past eight quarters, Liberty Latin America Ltd.'s revenue compounded faster (2.7% CAGR vs -2.1%).
Liberty Global Ltd. is a British-Dutch-American multinational telecommunications company domiciled in Bermuda, with headquarters in London, Amsterdam and Denver. Its respective legal names are Liberty Global Holdings Limited (UK), Liberty Global B.V. (Netherlands) and Liberty Global, Inc., with the first of these being publicly traded. It was formed in 2005 by the merger of the international arm of Liberty Media and UnitedGlobalCom (UGC).
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
LILA vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $2.3B |
| Net Profit | $-54.8M | $601.0M |
| Gross Margin | 77.3% | 71.7% |
| Operating Margin | 10.8% | — |
| Net Margin | -4.7% | 26.6% |
| Revenue YoY | 1.7% | 2.9% |
| Net Profit YoY | 74.0% | -0.2% |
| EPS (diluted) | $-0.27 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.3B | ||
| Q4 25 | $1.2B | $2.4B | ||
| Q3 25 | $1.1B | $2.4B | ||
| Q2 25 | $1.1B | $2.5B | ||
| Q1 25 | $1.1B | $2.2B | ||
| Q4 24 | $1.1B | $2.3B | ||
| Q3 24 | $1.1B | $2.4B | ||
| Q2 24 | $1.1B | $2.4B |
| Q1 26 | — | $601.0M | ||
| Q4 25 | $-54.8M | $603.0M | ||
| Q3 25 | $3.3M | $721.0M | ||
| Q2 25 | $-423.3M | $718.0M | ||
| Q1 25 | $-136.4M | $631.0M | ||
| Q4 24 | $-210.4M | $581.0M | ||
| Q3 24 | $-435.8M | $682.0M | ||
| Q2 24 | $-42.7M | $624.0M |
| Q1 26 | — | 71.7% | ||
| Q4 25 | 77.3% | 70.2% | ||
| Q3 25 | 77.7% | 71.5% | ||
| Q2 25 | 78.6% | 73.6% | ||
| Q1 25 | 78.5% | 72.0% | ||
| Q4 24 | 76.1% | 69.5% | ||
| Q3 24 | 78.7% | 70.6% | ||
| Q2 24 | 78.1% | 71.7% |
| Q1 26 | — | — | ||
| Q4 25 | 10.8% | 31.9% | ||
| Q3 25 | 16.9% | 37.0% | ||
| Q2 25 | -30.6% | 36.7% | ||
| Q1 25 | 11.8% | 36.5% | ||
| Q4 24 | 8.7% | 31.6% | ||
| Q3 24 | -34.9% | 36.6% | ||
| Q2 24 | 9.9% | 33.0% |
| Q1 26 | — | 26.6% | ||
| Q4 25 | -4.7% | 25.3% | ||
| Q3 25 | 0.3% | 30.0% | ||
| Q2 25 | -39.0% | 29.2% | ||
| Q1 25 | -12.6% | 28.4% | ||
| Q4 24 | -18.5% | 25.1% | ||
| Q3 24 | -40.0% | 28.6% | ||
| Q2 24 | -3.8% | 26.4% |
| Q1 26 | — | $1.42 | ||
| Q4 25 | $-0.27 | $1.37 | ||
| Q3 25 | $0.02 | $1.63 | ||
| Q2 25 | $-2.12 | $1.61 | ||
| Q1 25 | $-0.69 | $1.41 | ||
| Q4 24 | $-1.03 | $1.29 | ||
| Q3 24 | $-2.22 | $1.50 | ||
| Q2 24 | $-0.22 | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $783.9M | — |
| Total DebtLower is stronger | $7.9B | — |
| Stockholders' EquityBook value | $555.6M | — |
| Total Assets | $12.2B | — |
| Debt / EquityLower = less leverage | 14.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $783.9M | — | ||
| Q3 25 | $596.7M | $2.1B | ||
| Q2 25 | $514.4M | $1.4B | ||
| Q1 25 | $575.5M | $1.7B | ||
| Q4 24 | $654.3M | $2.0B | ||
| Q3 24 | $588.6M | $1.7B | ||
| Q2 24 | $598.6M | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | $7.9B | — | ||
| Q3 25 | $7.8B | — | ||
| Q2 25 | $7.6B | — | ||
| Q1 25 | $7.6B | — | ||
| Q4 24 | $7.6B | — | ||
| Q3 24 | $7.6B | — | ||
| Q2 24 | $7.6B | — |
| Q1 26 | — | — | ||
| Q4 25 | $555.6M | $3.3B | ||
| Q3 25 | $628.9M | $5.4B | ||
| Q2 25 | $608.4M | $5.0B | ||
| Q1 25 | $1.0B | $4.7B | ||
| Q4 24 | $1.1B | $4.8B | ||
| Q3 24 | $1.2B | $5.2B | ||
| Q2 24 | $1.7B | $5.0B |
| Q1 26 | — | — | ||
| Q4 25 | $12.2B | $15.5B | ||
| Q3 25 | $12.0B | $15.2B | ||
| Q2 25 | $12.0B | $14.5B | ||
| Q1 25 | $12.6B | $14.1B | ||
| Q4 24 | $12.8B | $14.2B | ||
| Q3 24 | $12.7B | $14.4B | ||
| Q2 24 | $13.2B | $14.2B |
| Q1 26 | — | — | ||
| Q4 25 | 14.17× | — | ||
| Q3 25 | 12.45× | — | ||
| Q2 25 | 12.50× | — | ||
| Q1 25 | 7.47× | — | ||
| Q4 24 | 6.99× | — | ||
| Q3 24 | 6.20× | — | ||
| Q2 24 | 4.59× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $461.9M | — |
| Free Cash FlowOCF − Capex | $320.1M | — |
| FCF MarginFCF / Revenue | 27.6% | — |
| Capex IntensityCapex / Revenue | 12.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $305.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $461.9M | $893.0M | ||
| Q3 25 | $178.2M | $938.0M | ||
| Q2 25 | $141.2M | $486.0M | ||
| Q1 25 | $24.6M | $587.0M | ||
| Q4 24 | $398.6M | $905.0M | ||
| Q3 24 | $177.5M | $951.0M | ||
| Q2 24 | $156.9M | $502.0M |
| Q1 26 | — | — | ||
| Q4 25 | $320.1M | $732.0M | ||
| Q3 25 | $56.0M | $805.0M | ||
| Q2 25 | $1.9M | $308.0M | ||
| Q1 25 | $-72.1M | $438.0M | ||
| Q4 24 | $234.9M | $689.0M | ||
| Q3 24 | $51.0M | $784.0M | ||
| Q2 24 | $16.4M | $370.0M |
| Q1 26 | — | — | ||
| Q4 25 | 27.6% | 30.7% | ||
| Q3 25 | 5.0% | 33.5% | ||
| Q2 25 | 0.2% | 12.5% | ||
| Q1 25 | -6.7% | 19.7% | ||
| Q4 24 | 20.6% | 29.7% | ||
| Q3 24 | 4.7% | 32.8% | ||
| Q2 24 | 1.5% | 15.7% |
| Q1 26 | — | — | ||
| Q4 25 | 12.2% | 6.7% | ||
| Q3 25 | 11.0% | 5.5% | ||
| Q2 25 | 12.8% | 7.2% | ||
| Q1 25 | 8.9% | 6.7% | ||
| Q4 24 | 14.4% | 9.3% | ||
| Q3 24 | 11.6% | 7.0% | ||
| Q2 24 | 12.6% | 5.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.48× | ||
| Q3 25 | 54.00× | 1.30× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | — | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LILA
| Liberty Cablevisionof Puerto Rico LLC Liberty Puerto Rico | $301.3M | 26% |
| Cable Wireless Communications Limited CW Panama | $230.1M | 20% |
| Costa Rica Segment | $168.2M | 15% |
| Liberty Networks | $129.3M | 11% |
| Cable Subscription | $112.4M | 10% |
| Mobile Subscription | $95.9M | 8% |
| Mobile Handset And Other Devices | $73.0M | 6% |
| Liberty Networks Other | $25.0M | 2% |
| Mobile Non Subscription | $21.6M | 2% |
| B2B Mobile Handsetand Other Devices | $7.0M | 1% |
| Cable Non Subscription | $4.3M | 0% |
ZTS
| Companion Animal | $1.5B | 67% |
| Livestock | $720.0M | 32% |
| Contract Manufacturing & Human Health | $23.0M | 1% |
